Biological active acridine derivatives, 2. Chiral 9-aminoacridines. 1994

S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
A. V. Bogatsky Physico-Chemical Insitute, Academy of Sciences, Odessa, Ukraine.

UI MeSH Term Description Entries
D002044 Bunyaviridae Infections Virus diseases caused by the BUNYAVIRIDAE. Bunyavirus Infections,Infections, Bunyaviridae,Infections, Bunyavirus,Oropouche Fever,Oropouche Infection,Oropouche Orthobunyavirus Infection,Oropouche Virus Infection,Orthobunyavirus Infections,Bunyaviridae Infection,Bunyavirus Infection,Oropouche Fevers,Orthobunyavirus Infection,Orthobunyavirus Infection, Oropouche,Virus Infection, Oropouche
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D000609 Aminoacridines Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012295 Rift Valley Fever An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion (ABORTION, VETERINARY); and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS. Fever, Rift Valley
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
June 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
October 1972, Journal of pharmaceutical sciences,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
August 1976, Journal of medicinal chemistry,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
January 2005, Acta crystallographica. Section C, Crystal structure communications,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
January 2000, Acta poloniae pharmaceutica,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
February 2004, Molecules (Basel, Switzerland),
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
March 2010, Acta crystallographica. Section E, Structure reports online,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
July 2004, Archives of pharmacal research,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
October 2023, ACS omega,
S A Lyakhov, and I Suveyzdis Ya, and L K Berezina, and S A Andronati, and D K Lvov, and L A Litvinova, and R V Denisenko
February 2005, Acta crystallographica. Section C, Crystal structure communications,
Copied contents to your clipboard!